» Articles » PMID: 37299457

Early Life Obesity Increases Neuroinflammation, Amyloid Beta Deposition, and Cognitive Decline in a Mouse Model of Alzheimer's Disease

Overview
Journal Nutrients
Date 2023 Jun 10
PMID 37299457
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity, a known risk factor of Alzheimer's disease (AD), increases the activation of microglia, leading to a proinflammatory phenotype. Our previous work shows that a high fat diet (HFD) can cause neuroinflammation and cognitive decline in mice. We hypothesized that proinflammatory activation of brain microglia in obesity exacerbates AD pathology and increases the accumulation of amyloid beta (Aβ) plaques. Presently, we tested cognitive function in 8-month-old male and female APP/PS1 mice fed a HFD, starting at 1.5 months of age. Locomotor activity, anxiety-like behavior, behavioral despair, and spatial memory were all assessed through behavioral tests. Microgliosis and Aβ deposition were measured in multiple brain regions through immunohistochemical analysis. Our results show that a HFD decreases locomotor activity, while increasing anxiety-like behavior and behavioral despair independent of genotype. A HFD led to increased memory deficits in both sexes, with HFD-fed APP/PS1 mice performing the worst out of all groups. Immunohistochemical analysis showed increased microgliosis in mice fed a HFD. This was accompanied by an increase in Aβ deposition in the HFD-fed APP/PS1 mice. Together, our results support that HFD-induced obesity exacerbates neuroinflammation and Aβ deposition in a young adult AD mouse model, leading to increased memory deficits and cognitive decline in both sexes.

Citing Articles

Dapagliflozin Improves High-Fat Diet-Induced Cognitive Impairment in Female Mice.

Chen X, Fan M, Xiao Z, Xiong X Brain Behav. 2025; 15(2):e70361.

PMID: 39972998 PMC: 11839776. DOI: 10.1002/brb3.70361.


Long-Term High-Fat Diet Impairs AQP4-Mediated Glymphatic Clearance of Amyloid Beta.

Peng W, Yuan Y, Lei J, Zhao Y, Li Y, Qu Q Mol Neurobiol. 2024; 62(1):1079-1093.

PMID: 38958889 DOI: 10.1007/s12035-024-04320-3.


Qingzhuan dark tea Theabrownin alleviates hippocampal injury in HFD-induced obese mice through the MARK4/NLRP3 pathway.

Lei Y, Chen Y, Zhang S, Wang W, Zheng M, Zhang R Heliyon. 2024; 10(5):e26923.

PMID: 38455533 PMC: 10918207. DOI: 10.1016/j.heliyon.2024.e26923.


Alzheimer's disease, a metabolic disorder: Clinical advances and basic model studies (Review).

Zhou S, Tu L, Chen W, Yan G, Guo H, Wang X Exp Ther Med. 2024; 27(2):63.

PMID: 38234618 PMC: 10792406. DOI: 10.3892/etm.2023.12351.

References
1.
Moreno-Gonzalez I, Edwards Iii G, Salvadores N, Shahnawaz M, Diaz-Espinoza R, Soto C . Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding. Mol Psychiatry. 2017; 22(9):1327-1334. PMC: 5495631. DOI: 10.1038/mp.2016.230. View

2.
Mormino E, Papp K . Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease. J Alzheimers Dis. 2018; 64(s1):S633-S646. PMC: 6387885. DOI: 10.3233/JAD-179928. View

3.
Bamberger M, Harris M, McDonald D, Husemann J, Landreth G . A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J Neurosci. 2003; 23(7):2665-74. PMC: 6742111. View

4.
Anstey K, Cherbuin N, Budge M, Young J . Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev. 2011; 12(5):e426-37. DOI: 10.1111/j.1467-789X.2010.00825.x. View

5.
Attar A, Liu T, Chan W, Hayes J, Nejad M, Lei K . A shortened Barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer's disease. PLoS One. 2013; 8(11):e80355. PMC: 3827415. DOI: 10.1371/journal.pone.0080355. View